Skip to main content
. 2016 Oct 19;312(1):F96–F108. doi: 10.1152/ajprenal.00272.2016

Table 1.

Compositions of solutions (mM)

KCl NaCl KMeSO3 CaCl2 CaGluc MgCl2 MgGluc HEPES BAPTA DibromoBAPTA HEDTA d-Glucose
Cytoplasmic
    0.1 µM free Ca2+ (standard) 140 5 0.7 2 5 2 5
    1–3 µM free Ca2+ 140 5 0.9–1.4 2 5 2 5
    10–30 µM free Ca2+ 140 5 0.8–1.4 2 5 2 5
    300 µM free Ca2+ 140 5 2.3 2 5 2 5
    1 mM free Ca2+ 140 5 1 2 5 5
    High-K+, 0.1–300 µM free Ca2+ 145 * 2 5 * * * 5
    High-Na+, 3 µM free Ca2+ 145 1.4 2 5 2 5
    High-Na+, 300 µM free Ca2+ 145 2.3 2 5 2 5
    Cl¯-free, 3 µM free Ca2+ 145 1.4 2 5 2 5
    Cl¯-free, 300 µM free Ca2+ 145 2.3 2 5 2 5
NaCl KCl CaCl2 MgCl2 HEPES NaPyr d-Glucose
External
    Standard 140 5 2 2 5 2 9.4
    High-K+ 145 2 2 5 2 9.4
    High-Ca2+ 100 2 5 9.4

BAPTA and dibromoBAPTA were added as the tetrapotassium salts and HEDTA as the tripotassium salt. In solutions containing 300 µM free Ca2+, the Ca2+ buffer (BAPTA) was saturated. Solutions were adjusted to pH 7.4 with the hydroxide of the principal cation, or with Tris base (high-Ca2+ external solution). KMeSO3, potassium methanesulfonate; CaGluc, calcium gluconate; MgGluc, magnesium gluconate; NaPyr, sodium pyruvate.

*

Concentrations of CaCl2 and Ca2+ buffer (BAPTA, dibromoBAPTA, or HEDTA) are as shown for the first set of four solutions.